Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Terminated 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Leiomyoma 6Menorrhagia 3

Interventions

estradiol, norethindrone drug combination 7asoprisnil 6relugolix 5Estradiol 5elagolix 4vilaprisan 3Norethindrone Acetate 3linzagolix 2Uterine Artery Embolization 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Hysterectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Menorrhagia × vilaprisan × Clear all
NCT03400943 2023-05-03

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)

Bayer

Phase 3 Terminated
93 enrolled 19 charts

Leiomyoma, Menorrhagia

NCT03476928 2022-07-08

ASTEROID 8

Bayer

Phase 3 Terminated
153 enrolled

Leiomyoma, Menorrhagia

NCT03400956 2022-06-30

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)

Bayer

Phase 3 Terminated
103 enrolled 18 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡